Abstract:Abstract Learning Objectives After completing this course, the reader will be able to: Describe the presentation, differential diagnosis, and prognosis for patients with Ewing's sarcoma.Explain the principles of multidisciplinary management of Ewing's sarcoma.Discuss the late effects of the therapy for Ewing's sarcoma. Access and take the CME test online and receive 1 AMA PRA category 1 credit at CME.TheOncologist.com Ewing's sarcoma is the second most frequent primary bone cancer, with approximately 225 new cases diagnosed each year in patients less than 20 years of age in North America. It is one of the pediatric small round blue cell tumors, characterized by strong membrane expression of CD99 in a chain-mail pattern and negativity for lymphoid (CD45), rhabdomyosarcoma (myogenin, desmin, actin) and neuroblastoma (neurofilament protein) markers. Pathognomonic translocations involving the ews gene on chromosome 22 and an ets-type gene, most commonly the fli1 gene on chromosome 11, are implicated in the great majority of cases. Clinical presentation is usually dominated by local bone pain and a mass. Imaging reveals a technetium pyrophosphate avid lesion that, on plain radiograph, is destructive, diaphyseal and classically causes layered periosteal calcification. Magnetic resonance best defines the extent of the lesion. Biopsy should be undertaken by an experienced orthopedic oncologist. Approximately three quarters of patients have initially localized disease. About two thirds survive disease-free. Management, preferably at a specialist center with a multi-disciplinary team, includes both local control—either surgery, radiation or a combination—and systemic chemotherapy. Chemotherapy includes cyclic combinations, incorporating vincristine, doxorubicin, cyclophosphamide, etoposide, ifosfamide and occasionally actinomycin D. Topotecan in combination with cyclophosphamide has shown preliminary activity. Patients with initially metastatic disease fare less well, with about one quarter surviving. Studies incorporating intensive therapy followed by stem cell infusion show no clear benefit. New approaches include anti-angiogenic therapy, particularly since vascular endothelial growth factor is an apparent downstream target of the ews-fli1 oncogene.

[The effect of swimming on the nasal passages and on tube function in children].

Clinical Features and Prognostic Factors in Elderly Ewing Sarcoma Patients.

Efficacy of combined surgery and irradiation for localized Ewings sarcoma family of tumors

Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors: local outcome and prognostic factors

Analysis of prognostic factors in extraosseous Ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital experience

Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Kidney: The MD Anderson Cancer Center Experience

Primary Chest Wall Ewing Sarcoma: Treatment and Long-Term Results

Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: outcome and prognostic factors

Therapy for localized Ewing's sarcoma of bone

Ewing Sarcoma: Current Management and Future Approaches Through Collaboration

Does surgery or radiation provide the best overall survival in Ewing's sarcoma? A review of the National Cancer Data Base

Radiation therapy dose escalation achieves high rates of local control with tolerable toxicity profile in pediatric and young adult patients with Ewing sarcoma

Primary Adult Renal Ewing's Sarcoma: A Rare Entity

[Analysis of 41 cases of non-metastatic Ewing's sarcoma in children].

Advances in multi-therapies for the treatment of Ewing's sarcoma

Generation of leukotrienes by purified human lung mast cells.

Prognostic factors for local and distant control in Ewing sarcoma family of tumors

Advances in Chemotherapy and Radiotherapy Combined with Molecular Targeted Therapy for Ewing's Sarcoma

Ewing's Sarcoma Family of Tumors: Current Management

Ewing Sarcoma in the Pediatric Population: Predictors of Survival Within the United States

Current Status of Management and Outcome for Patients with Ewing Sarcoma